Clinical Pharmacokinetics

Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development
pp. 1-22(22)
Authors: Eriksson, Bengt I.; Quinlan, Daniel J.; Weitz, Jeffrey I.

Ketolides - The Modern Relatives of Macrolides: The Pharmacokinetic Perspective
pp. 23-38(16)
Authors: Zeitlinger, Markus; Claudia Christina Wagner,; Heinisch, Birgit

Lack of Pharmacokinetic Interaction of Mipomersen Sodium (ISIS 301012), a 2′-O-Methoxyethyl Modified Antisense Oligonucleotide Targeting Apolipoprotein B-100 Messenger RNA, with Simvastatin and Ezetimibe
pp. 39-50(12)
Authors: Yu, Rosie Z.; Geary, Richard S.; Flaim, JoAnn D.; Riley, Gina C.; Tribble, Diane L.; vanVliet, André A.; Wedel, Mark K.

Population Pharmacokinetic Analysis of Lanreotide Autogel® in Healthy Subjects: Evidence for Injection Interval of Up to 2 Months
pp. 51-62(12)
Authors: Trocóniz, Iñaki F.; Cendrós, Josep-María; Peraire, Concepción; Ramis, Joaquim; Garrido, Maria J.; Boscani, Paolo F.; Obach, Rosendo

Steady-State Concentrations of Mirtazapine, N-Desmethylmirtazapine, 8-Hydroxymirtazapine and their Enantiomers in Relation to Cytochrome P450 2D6 Genotype, Age and Smoking Behaviour
pp. 63-70(8)
Authors: Lind, Anna-Britta; Reis, Margareta; Bengtsson, Finn; Jonzier-Perey, Michele; Kerry Powell Golay,; Ahlner, Johan; Baumann, Pierre; Dahl, Marja-Liisa